Literature DB >> 1105975

A new reversed passive hemagglutination test for detection of HBsAg.

A M Prince, H Ikram, D Chicot, R Wright, J Vnek, R Neurath, A Lippin, S Swiss.   

Abstract

A new reversed passive hemagglutination test for HBsAg, termed Raphadex B, has been developed using immunochemically purified chimpanzee anti-HBs bound to stabilized human erythrocytes. The test has been found to have equivalent sensitivity to the Ausria 125I radioimmunoassay, and detected a similar number of HBsAg-containing specimens in screening of volunteer blood donors. This method offers an economical approach to third generation methodology for hepatitis B screening of blood donors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1105975     DOI: 10.1111/j.1423-0410.1975.tb00516.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

1.  Correlations between the detection of e antigen or antibody and electron microscopic pattern of hepatitis B surface antigen (HBsAg) associated particles in the serum of HBsAg carriers.

Authors:  C Trepo; R G Bird; A J Zuckerman
Journal:  J Clin Pathol       Date:  1977-03       Impact factor: 3.411

2.  Preparation and use of erythrocyte-globulin conjugates to Lassa virus in reversed passive hemagglutination and inhibition.

Authors:  R A Goldwasser; L H Elliott; K M Johnson
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

3.  Serological differentiation between infected and vaccinated cattle by using purified soluble antigens from Brucella abortus in a hemagglutination system.

Authors:  T J Raybould; S Chantler
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.